News

Generic sildenafil approved for erectile dysfunction


 

References

The first generic version of sildenafil citrate has been approved for the treatment of erectile dysfunction, the Food and Drug Administration has announced.

Teva Pharmaceutical Industries received approval to market generic sildenafil citrate tablets in 25-mg, 50-mg, and 100-mg doses and has been granted 180-day exclusivity, according to the FDA.

mdales@frontlinemedcom.com

Recommended Reading

Testosterone therapy didn’t boost atherosclerosis over 3 years
MDedge Endocrinology
Testosterone regimen may affect cardiovascular risk
MDedge Endocrinology
Recall issued on U.S. Compounding sterile products
MDedge Endocrinology
AACE releases new position statement on testosterone replacement therapy in men
MDedge Endocrinology
Experts call for international cooperation on human gene editing
MDedge Endocrinology
ADT linked to increased risk of Alzheimer’s disease
MDedge Endocrinology
FDA finalizes 1-year blood donor deferral for gay, bisexual men
MDedge Endocrinology
Testicular cancer patients who fare well early on have smooth sailing thereafter
MDedge Endocrinology
Statins don’t appear to compromise effectiveness of abiraterone
MDedge Endocrinology
Testosterone: Moderate sexual, mood benefits; no vitality benefit
MDedge Endocrinology